MetaMorphix® has a strong intellectual property position in the enabling technologies being utilized to develop innovative products.
MetaMoprhix’s intellectual property portfolio includes 47 issued
U.S.
patents and 41 U.S. Pending applications. MetaMorphix® owns exclusive worldwide rights to develop agricultural applications of the Myostatin Technology.
